Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06782529 · ClinicalTrials.gov registry record · Phase 4
Knee Injections for Obese Patients With Knee Arthritis
A Phase 4 study of Osteoarthritis of Knee, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT06782529 is a Phase 4 study of Osteoarthritis of Knee that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 40 participants, below the 227-participant average among 3 other Osteoarthritis of Knee trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06782529, a Phase 4 study of Osteoarthritis of Knee, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess obese patients with knee arthritis and determine the non-inferiority of a low dose steroid treatment vs. standard dose steroid treatment for two knee outcome measures: pain and function.
Conditions Studied
Interventions
- DRUG Triamcinolone Acetonide Low Dose
- DRUG Triamcinolone Acetonide Standard Dose
Study Locations (1)
Florida
- Mayo Clinic in Florida - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-01-24 |
| Est. Completion | 2027-01-24 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06782529
The ClinicalTrials.gov registry entry for NCT06782529 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 227-participant average among 3 other Osteoarthritis of Knee trials with a reported enrollment target (82% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Osteoarthritis of Knee appearing as the primary indexed condition, and to 2 interventions - of which Triamcinolone Acetonide Low Dose is the first listed.
NCT06782529 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT06782529 about?
NCT06782529 is a clinical study titled "Knee Injections for Obese Patients With Knee Arthritis". The purpose of this study is to assess obese patients with knee arthritis and determine the non-inferiority of a low dose steroid treatment vs. standard dose steroid treatment for two knee outcome measures: pain and function.
What is the current status of trial NCT06782529?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2025-01-24. Estimated completion is 2027-01-24.
What conditions does trial NCT06782529 study?
This clinical trial studies the following conditions: Osteoarthritis of Knee.
What interventions are being tested in trial NCT06782529?
The interventions under investigation include: Triamcinolone Acetonide Low Dose (DRUG), Triamcinolone Acetonide Standard Dose (DRUG).
Who is sponsoring clinical trial NCT06782529?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06782529 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis of Knee
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Computer-guided Action Planning to Support Physical Activity (CAPPA) for Employees with Chronic Knee Symptoms
RECRUITING · NA
-
A Phase 1/2a to Evaluate the Safety and Efficacy of Adipose Tissue Allograft (BRC-OA) in Patients With Osteoarthritis of the Knee
RECRUITING · Phase 1
-
A Study to Evaluate Efficacy and Safety of AMZ001 for the Treatment of Knee Osteoarthritis Symptoms
ACTIVE NOT RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.